BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16163166)

  • 1. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 3. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 5. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
    Andersen O
    Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
    [No Abstract]   [Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG; Kimberlin RH
    Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prions and transfusion medicine.
    Budka H
    Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years.
    Martin M; Trouvin JH
    Transfus Clin Biol; 2013 Sep; 20(4):398-404. PubMed ID: 23910008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised precautionary measures to reduce the possible transmission of Creutzfeldt-Jakob disease (CJD) by blood and blood products; guidance document; availability--FDA. Notice.
    Fed Regist; 1997 Sep; 62(184):49694-5. PubMed ID: 10173801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA wants more restrictions on donated blood.
    Mitka M
    JAMA; 2001 Jul; 286(4):408. PubMed ID: 11466114
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
    Brown P; Cervenáková L; Diringer H
    J Lab Clin Med; 2001 Jan; 137(1):5-13. PubMed ID: 11150018
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symposium on prions and transfusion safety.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):393-4. PubMed ID: 23928184
    [No Abstract]   [Full Text] [Related]  

  • 19. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM; Dickinson J; Walker JT; Raven ND
    Clin Infect Dis; 2006 Sep; 43(6):757-64. PubMed ID: 16912952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.